SEC Form 4 · accession 0000899243-17-029322
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard D Schaeffer
Director
Period of report
Dec 19, 2017
Accepted (ET)
Dec 20, 2017 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2017 | M | 22,631 | $1.66 | A | 57,449 | D | |
| Common StockF1 | holding | — | — | — | 43,104 | I | By: Schaeffer Holdings LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.66 | Dec 19, 2017 | M | 22,631 | D | — | Sep 17, 2024 | Common Stock | 22,631 | 5,223 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose.
- F225% of the shares vested on September 17, 2015, and an additional 1/48th vests on the last day of each one month period thereafter.